Prudential Financial
RVLP

Prudential Financial’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Prudential Financial’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25,000
Closed -$34K – 2745
2022
Q2 		$34K Buy
+25,000
New +$36.2K ﹤0.01% 2605
2021
Q2 		– Sell
-146,090
Closed -$476K – 2633
2021
Q1 		$476K Sell
146,090
-12,360
-8% -$50.8K ﹤0.01% 2150
2020
Q4 		$652K Hold
158,450
– – ﹤0.01% 1950
2020
Q3 		$857K Buy
158,450
+123,783
+357% +$713K ﹤0.01% 1714
2020
Q2 		$233K Buy
+34,667
New +$170K ﹤0.01% 2203

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Prudential Financial's RVLP Position: Q3 2022 in Review

Prudential Financial sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2022, closing a stake of 25,000 shares — an estimated $34K sold.

Prudential Financial first reported a position in RVLP in Q2 2020 and held it in 5 quarters. The position peaked at $857K in Q3 2020. 46 funds tracked by Wall St. Rank hold RVLP as of Q3 2022.

  • Prudential Financial reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Prudential Financial sold 25,000 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2022, an estimated $34K.
  • Prudential Financial first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q2 2020 and held it in 5 quarters.
  • Prudential Financial's RVL Pharmaceuticals plc Ordinary Shares position peaked at $857K in Q3 2020.
  • 46 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2022.

Based on Prudential Financial's 13F filing for Q3 2022, filed 4 Nov 2022.